Clinical trial
Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea
NCT00392574 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00392574 |
|---|---|
| Title | Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea |
| Official title | A Multicenter, Double-Blind, Randomized Study to Compare The Safety and Efficacy of Prulifloxacin Versus Placebo in the Treatment of Acute Gastroenteritis in Adult Travelers |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Gastroenteritis in Adult Travelers |
| Intervention type | Drug |
| Interventions | Prulifloxacin, Placebo |
| Enrollment | 282 |
| Start date | Aug 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Oct 26, 2006 |
| Last update posted | May 15, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: